Asthmapolis, a Madison, WI-based mobile health solution for asthma and COPD, raised $5m in a Series A funding.
Backers included Palo Alto, California-based The Social+Capital Partnership.
The company intends to use the funds to deliver new innovations and services for its solution.
Co-founded in 2010 by David Van Sickle, CEO, and Mark Gehring, president, Asthmapolis uses a combination of smartphone applications and snap-on inhaler sensors that track when and how often patients use their inhaled medications. The company’s geomedicine platform, available in both English and Spanish, is designed to help individuals with their daily preventive medications, reveal insights about their use of rescue medications and provide personalized feedback to improve their ability to manage the disease.
In conjunction with the funding, Ted Maidenberg, Social Capital’s general partner, joined Asthmapolis’ board of directors.
The company is hiring for engineering, design, asthma education and other roles (read here).